Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection

Author:

Chen Weijun1,Xu Zuyuan1,Mu Jingsong1,Yang Ling1,Gan Haixue1,Mu Feng1,Fan Baoxing1,He Bo1,Huang Shengyong1,You Bo1,Yang Yongkui1,Tang Xiangjun1,Qiu Ling1,Qiu Yan1,Wen Jie1,Fang Jianqiu1,Wang Jian1

Affiliation:

1. Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300, China 2Beijing BGI-GBI Biotech Co. Ltd, Beijing 101300, China 3Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China 4Beijing 302 Hospital, Beijing 100039, China 5Beijing 301 Hospital, Beijing 100853, China 6Beijing Union Hospital, Beijing 100730, China 7Beijing Red Cross Blood Center, Beijing 100088, China

Abstract

To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference17 articles.

1. & 23 other authors;Drosten;N Engl J Med,2003

2. & 9 other authors;Gao;Chin J Blood Transfus,2003

3. & 23 other authors;Ksiazek;N Engl J Med,2003

4. & 11 other authors;Lee;N Engl J Med,2003

5. Profile of specific antibodies to the SARS-associated coronavirus;Li;N Engl J Med,2003

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3